Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00060606 · ClinicalTrials.gov registry record · NA
Management of Myelomeningocele Study (MOMS)
A NA study, sponsored by The George Washington University Biostatistics Center.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
NCT00060606 is a NA study that has completed, run by The George Washington University Biostatistics Center. The registered enrollment target is 183 participants.
The verdict
NCT00060606, a NA study, has completed, sponsored by The George Washington University Biostatistics Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
Study Summary
Spina bifida (myelomeningocele) is a complex birth defect in which a portion of the spinal cord is not fully developed. The overlying bones and skin are incompletely formed and the underdeveloped area of the spinal cord is exposed on the surface of the back. Spina bifida defects are closed soon after birth to prevent further damage to the spinal cord and nerves. The Management of Myelomeningocele Study (MOMS) is a research study comparing two approaches to the treatment of babies with spina bifida: surgery before birth (prenatal surgery) and the standard closure, surgery after birth (postnatal surgery).
Interventions
- PROCEDURE Prenatal Myelomeningocele Repair Surgery
- PROCEDURE Postnatal Myelomeningocele Repair Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2003-02 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00060606
The ClinicalTrials.gov registry entry for NCT00060606 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prenatal Myelomeningocele Repair Surgery is the first listed.
NCT00060606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00060606 about?
NCT00060606 is a clinical study titled "Management of Myelomeningocele Study (MOMS)". Spina bifida (myelomeningocele) is a complex birth defect in which a portion of the spinal cord is not fully developed. The overlying bones and skin are incompletely formed and the underdeveloped area of the spinal cord is exposed on the surface of the back. Spina bifida defects are closed soon afte...
What is the current status of trial NCT00060606?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2003-02. Estimated completion is 2017-06.
What interventions are being tested in trial NCT00060606?
The interventions under investigation include: Prenatal Myelomeningocele Repair Surgery (PROCEDURE), Postnatal Myelomeningocele Repair Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00060606?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.